A carregar...

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and EGCG: the role of p53-dependent inhibition of nuclear factor-kappaB

We have previously reported that the green tea polyphenol epigallocatechin-3-gallate (EGCG) and the epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) erlotinib had synergistic growth inhibitory effects in cell culture and a nude mouse xenograft model of squamous cell carcinoma of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Amin, ARM R., Khuri, Fadlo R., Chen, Zhuo (Georgia), Shin, Dong M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3744235/
https://ncbi.nlm.nih.gov/pubmed/19470788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0063
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!